Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
AssigneeAmrad Corporation Limited
InventorsNicholas M. Gough, Tracey A. Willson, Robert F. Seamark
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to the isolation of leukaemia inhibitory factor (LIF) genes from livestock species, the expression of said genes in recombinant vectors and the isolation of the recombinant LIF molecules and the use of livestock species LIF to enhance the in vitro development of an embryo to the implantation stage.
Claims7
A method for the in vitro development of a mammalian embryo to the implantation stage which method comprises the step of culturing the embryo in vitro in a culture medium containing an effective amount of mammalian LIF and for a time and under conditions sufficient to increase the percentage of eight cell embryos which reach the implantation stage.
Dependencies are inferred from the claim text.